Next Article in Journal
Professionalism
Previous Article in Journal
Dasatinib for a Child with Philadelphia Chromosome–Positive Acute Lymphoblastic Leukemia and Persistently Elevated Minimal Residual Disease during Imatinib Therapy
 
 
Current Oncology is published by MDPI from Volume 28 Issue 1 (2021). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Multimed Inc..
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Editorial

BRCA1/2 Population Screening: Embracing the Benefits

1
Departments of Pediatrics/Hematology-Oncology and Molecular and Human Genetics, Baylor College of Medicine, Houston, TX, USA
2
Human Genome Sequencing Center, Baylor College of Medicine, Houston, TX, USA
3
Texas Children’s Cancer Center, Texas Children’s Hospital, Houston, TX, USA
Curr. Oncol. 2015, 22(4), 230-231; https://doi.org/10.3747/co.22.2660
Submission received: 7 May 2015 / Revised: 10 June 2015 / Accepted: 2 July 2015 / Published: 1 August 2015

Excerpt

Note: In lieu of an abstract, this is an excerpt from the first page.

Whether all adult Ashkenazi women should be offered population screening for recurrent [...]

Share and Cite

MDPI and ACS Style

Plon, S.E. BRCA1/2 Population Screening: Embracing the Benefits. Curr. Oncol. 2015, 22, 230-231. https://doi.org/10.3747/co.22.2660

AMA Style

Plon SE. BRCA1/2 Population Screening: Embracing the Benefits. Current Oncology. 2015; 22(4):230-231. https://doi.org/10.3747/co.22.2660

Chicago/Turabian Style

Plon, S.E. 2015. "BRCA1/2 Population Screening: Embracing the Benefits" Current Oncology 22, no. 4: 230-231. https://doi.org/10.3747/co.22.2660

Article Metrics

Back to TopTop